无血性
心情
情绪障碍
心理学
生活质量(医疗保健)
临床心理学
精神科
老年学
精神分裂症(面向对象编程)
医学
焦虑
心理治疗师
作者
Alexis E. Whitton,Poornima Kumar,Michael T. Treadway,Ashleigh Rutherford,Manon L. Ironside,Dan Foti,Garrett M. Fitzmaurice,Fei Du,Diego A. Pizzagalli
标识
DOI:10.1038/s41380-023-02165-1
摘要
Leading professional health bodies have called for the wider adoption of Patient Reported Outcome Measures, such as quality of life, in research and clinical practice as a means for understanding why the global burden of depression continues to climb despite increased rates of treatment use. Here, we examined whether anhedonia—an often recalcitrant and impairing symptom of depression—along with its neural correlates, was associated with longitudinal changes in patient-reported quality of life among individuals seeking treatment for mood disorders. We recruited 112 participants, including n = 80 individuals with mood disorders (58 unipolar, 22 bipolar) and n = 32 healthy controls (63.4% female). We assessed anhedonia severity along with two electroencephalographic markers of neural reward responsiveness (scalp-level ‘Reward Positivity’ amplitude and source-localized reward-related activation in the dorsal anterior cingulate cortex), and assessed quality of life at baseline, 3- and 6-month follow-up. Anhedonia emerged as a robust correlate of quality of life cross-sectionally and longitudinally among individuals with mood disorders. Furthermore, increased neural reward responsiveness at baseline was associated with greater improvements in quality of life over time, and this improvement was mediated by longitudinal improvements in anhedonia severity. Finally, differences in quality of life observed between individuals with unipolar and bipolar mood disorders were mediated by differences in anhedonia severity. Our findings indicate that anhedonia and its reward-related neural correlates are linked to variability in quality of life over time in individuals with mood disorders. Treatments capable of improving anhedonia and normalizing brain reward function may be necessary for improving broader health outcomes for individuals seeking treatment for depression. ClinicalTrials.gov identifier: NCT01976975
科研通智能强力驱动
Strongly Powered by AbleSci AI